Exploiting Real-World Data From Social Media in Patient-Focused Drug Development
With the need to diversify the source of real-world data for regulatory purposes, the Pistoia Alliance and a few of its members set up a Community of Experts to evaluate interest in using social media for patient listening. Having identified that there is a clear need to define guidelines and best practices, the Pistoia Alliance is now launching a project that will evaluate regulators’ expectations, patients’ acceptance, data collection and analysis challenges. If you are interested in joining this new project, please contact thierry.escudier@pistoiaalliance.org.
SEED Project
Our SEED project which has brought together a rich set of expertise from industry and academia and a shared ethos that data standardization efforts should be collaborative has now closed having successfully delivered new ontology standards for ADME and drug safety which are available via BAO. The Journal of Biomedical Semantics will be publishing a paper on the project (≈Q4, 2023, “An extension of the BioAssay ontology to include Pharmacokinetic/Pharmacodynamic terminology for the enrichment of scientific workflows”). Our thanks go to project champion Steve Penn from Pfizer and everybody else who has contributed to this three-phased initiative including AstraZeneca, Bristol Myers Squibb, Scibite, Bayer, Biogen, Southampton University, GSK, CDD, Elsevier, Linguamatics, Merck, Sanofi, Takeda, ABBVIE, Chemaxon and Miami University. Steve will continue to advocate for shared data strategies and the consolidation of ontologies as a Pistoia Alliance steering committee member and can be contacted via steven.penn@pfizer.com.
D&I in STEM Leadership Program: Join our next cohort
Diversity and inclusion are critical to the success of the life sciences industry. Don’t miss the opportunity to take part in our next D&I in STEM Leadership cohort. This 12 week program educates new and experienced leaders on the many different aspects of diversity and helps them to proactively support D&I efforts with their teams and organizations. It also provides an opportunity for participants to build a diverse network of pharma leaders around the world. Find out more here.
New ideas for collaboration